Across
- 2. Loss of cell differentiation, indicative of malignancy.
- 4. Suppressor Gene that inhibits cell division and prevents malignancy.
- 6. Mutated gene that promotes uncontrolled cell proliferation.
- 9. Fat accumulation within cells, commonly in the liver.
- 13. Obstruction of a vessel by a detached clot or other material.
- 14. Fragmentation of a cell’s nucleus during cell death.
- 16. Malignant tumor of mesenchymal origin.
- 17. Reduced blood flow leading to tissue hypoxia.
- 18. Abnormal cellular growth, often a precursor to malignancy.
- 24. Excess fluid accumulation in interstitial spaces.
- 25. Condensation of nuclear material during cell death.
- 27. Reversible change where one adult cell type is replaced by another.
- 28. Excessive connective tissue deposition during chronic injury or healing.
- 29. Programmed cell death characterized by cell shrinkage and DNA fragmentation.
- 30. Tissue death due to inadequate blood supply.
Down
- 1. Aggregation of macrophages in response to persistent inflammation.
- 3. Syndrome Symptoms caused by substances secreted by a tumor.
- 5. Protective response to injury characterized by redness, swelling, and pain.
- 7. Malignant tumor of epithelial origin.
- 8. Localized dilation of a blood vessel due to wall weakness.
- 10. Deposition of misfolded protein aggregates in tissues.
- 11. Escape of blood from vessels due to injury or rupture.
- 12. Reduction in cell size or number due to disuse or nutrient deficiency.
- 15. Increase in cell size due to increased workload or stimulation.
- 19. Formation of new blood vessels, critical for tumor growth.
- 20. Dissolution of a nucleus due to enzymatic degradation.
- 21. Formation of a blood clot within a vessel.
- 22. Increase in cell number often due to hormonal stimulation.
- 23. Abnormal and uncontrolled new tissue growth.
- 26. Unregulated cell death leading to inflammation and tissue damage.